Vivek Ra­maswamy’s broth­er, Shankar, spins out on his own, launch­ing au­da­cious gene ther­a­py play

In 2018, when Vivek Ra­maswamy’s Ax­o­vant failed mul­ti­ple tri­als on its lead de­men­tia drug and piv­ot­ed the en­tire com­pa­ny to­ward gene ther­a­py, one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.